Owen Wallace, chief scientific officer of Monte Rosa Therapeutics, another biotech focused on MGDs, told pharmaphorum that this therapeutic approach also expands beyond just oncology, and into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback